News FDA and EMA reach milestone in sharing confidential informat... New agreement is culmination of three years of work by FDA and EMA
Views & Analysis Macron’s France: advancing towards a European vision for hea... What will Macron's government mean for healthcare in his country and Europe?
News Ireland steps up bid for European Medicines Agency Dublin the 'natural home' for EMA after Brexit
News UK medicines agency set to lose lucrative EMA work post-Brex... Agency already working on how to share post-Brexit workload.
News Don't let Brexit disrupt European Medicines Agency, warn pha... Heads of R&D at all major pharma companies have come together to express their concerns about severe disruption to the European Medicines Agency (EMA) as it faces a Brexit-induced reloc
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
